News - dapagliflozin, Johnson & Johnson

Filter

Popular Filters

Russia’s type 2 diabetes drug market will grow to $1.7 billion in 2015

13-10-2011

Russia’s type 2 diabetes drug market will grow more than seven percent annually from $1.2 billion…

AstraZenecaBristol-Myers SquibbcanagliflozindapagliflozinDiabetesEuropeJohnson & JohnsonMarkets & MarketingPharmaceutical

Back to top